Bath & Body Works’ (BBWI) “Outperform” Rating Reiterated at Telsey Advisory Group

Bath & Body Works (NYSE:BBWI)‘s stock had its “outperform” rating reaffirmed by investment analysts at Telsey Advisory Group in a report released on Monday,Benzinga reports. They presently have a $42.00 price target on the stock. Telsey Advisory Group’s target price suggests a potential upside of 37.93% from the stock’s current price.

BBWI has been the topic of several other reports. Citigroup reduced their price objective on shares of Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating on the stock in a report on Tuesday, August 20th. Robert W. Baird dropped their target price on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a research report on Thursday, August 29th. UBS Group dropped their target price on Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating for the company in a research report on Thursday, August 29th. Raymond James dropped their target price on Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating for the company in a research report on Thursday, August 29th. Finally, Bank of America dropped their target price on Bath & Body Works from $54.00 to $45.00 and set a “buy” rating for the company in a research report on Thursday, August 29th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and nine have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $42.44.

Bath & Body Works Trading Down 3.2 %

Shares of BBWI opened at $30.45 on Monday. The firm has a market cap of $6.67 billion, a P/E ratio of 7.37, a price-to-earnings-growth ratio of 1.00 and a beta of 1.79. Bath & Body Works has a 12-month low of $26.20 and a 12-month high of $52.99. The company’s 50-day moving average price is $30.34 and its 200 day moving average price is $36.18.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.02. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.54 billion. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. Equities research analysts forecast that Bath & Body Works will post 3.18 earnings per share for the current year.

Insider Transactions at Bath & Body Works

In other Bath & Body Works news, CEO Gina Boswell purchased 6,000 shares of the stock in a transaction that occurred on Wednesday, October 9th. The stock was purchased at an average cost of $29.64 per share, with a total value of $177,840.00. Following the completion of the acquisition, the chief executive officer now directly owns 242,987 shares of the company’s stock, valued at $7,202,134.68. This trade represents a 2.53 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.27% of the company’s stock.

Institutional Investors Weigh In On Bath & Body Works

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. CWM LLC raised its stake in shares of Bath & Body Works by 6.6% during the second quarter. CWM LLC now owns 5,072 shares of the company’s stock worth $198,000 after purchasing an additional 314 shares during the last quarter. Northwest Bank & Trust Co raised its stake in shares of Bath & Body Works by 2.5% during the first quarter. Northwest Bank & Trust Co now owns 13,094 shares of the company’s stock worth $655,000 after purchasing an additional 315 shares during the last quarter. DekaBank Deutsche Girozentrale raised its stake in shares of Bath & Body Works by 1.0% during the first quarter. DekaBank Deutsche Girozentrale now owns 31,797 shares of the company’s stock worth $1,560,000 after purchasing an additional 322 shares during the last quarter. TD Private Client Wealth LLC raised its stake in shares of Bath & Body Works by 24.2% during the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after purchasing an additional 331 shares during the last quarter. Finally, Citizens & Northern Corp raised its stake in shares of Bath & Body Works by 1.7% during the second quarter. Citizens & Northern Corp now owns 29,465 shares of the company’s stock worth $1,151,000 after purchasing an additional 487 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.